Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients: a MALDI study.

Urine samples from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients were analyzed by matrix assisted laser desorption/ionization (MALDI) mass spectrometry in order to establish evidence of some possible differences in the peptide profile related to the pathological states. Multivariate analysis suggested the possibility of a distinction among the considered groups of patients. Some differences have been found, in particular, in the relative abundances of three ions at m/z 1912, 1219 and 2049. For these reasons, further investigation was carried out by MALDI/TOF/TOF to determine the sequence of these peptides and, consequently, to individuate their possible origin. By this approach, the peptide at m/z 1912 was found to originate from uromodulin, and its lower expression in the case of nephropathy can be well related to the pathological condition. Ions at m/z 2049 and 1219 originate from the collagen alpha-1(I) chain precursor and from the collagen alpha-5 (IV) chain precursor, respectively, and, also in this case, their different expressions can be related to the pathologies under investigation. The obtained data seem to indicate that urine is an interesting biological fluid to investigate on the peptide profile and to obtain, consequently, information on the dismetabolism activated by specific pathologies.

[1]  J. A. Hartigan,et al.  A k-means clustering algorithm , 1979 .

[2]  Maurice K. Wong,et al.  Algorithm AS136: A k-means clustering algorithm. , 1979 .

[3]  T. Pihlajaniemi,et al.  Complete primary structure of the triple-helical region and the carboxyl-terminal domain of a new type IV collagen chain, alpha 5(IV). , 1990, The Journal of biological chemistry.

[4]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  H. King,et al.  Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.

[6]  Zheng Xie,et al.  AMADA: analysis of microarray data , 2001, Bioinform..

[7]  Koichi Yoshioka,et al.  KyPlot – A User-oriented Tool for Statistical Data Analysis and Visualization , 2002, Comput. Stat..

[8]  M. Lise,et al.  Cluster analysis of serum proteins in malignant cutaneous melanoma: search for disease markers. , 2003, Rapid communications in mass spectrometry : RCM.

[9]  Hugh M. Cartwright,et al.  SpecAlign - processing and alignment of mass spectra datasets , 2005, Bioinform..

[10]  K. Dahan,et al.  Tamm-Horsfall protein or uromodulin: new ideas about an old molecule. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  S. Mocellin,et al.  Search for Melanoma Markers in Plasma and Serum Samples , 2005, European journal of mass spectrometry.

[12]  H. Bächinger,et al.  Collagen : primer in structure, processing and assembly , 2005 .

[13]  M. Agostini,et al.  Multivariate analysis approach to the plasma protein profile of patients with advanced colorectal cancer. , 2006, Journal of mass spectrometry : JMS.

[14]  Paul J Thornalley,et al.  Advanced glycation endproducts: what is their relevance to diabetic complications? , 2007, Diabetes, obesity & metabolism.

[15]  E. Ragazzi,et al.  Multivariate analysis of matrix-assisted laser desorption/ionization mass spectrometric data related to glycoxidation products of human globins in nephropathic patients , 2007, Journal of the American Society for Mass Spectrometry.

[16]  S. Satchell,et al.  What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? , 2008, Diabetologia.